7.46
price down icon2.93%   -0.225
pre-market  プレマーケット:  7.45   -0.010   -0.13%
loading
前日終値:
$7.685
開ける:
$7.53
24時間の取引高:
31,127
Relative Volume:
0.01
時価総額:
$16.70M
収益:
$74,000
当期純損益:
$-13.43M
株価収益率:
-0.7936
EPS:
-9.4
ネットキャッシュフロー:
$-10.54M
1週間 パフォーマンス:
-4.60%
1か月 パフォーマンス:
-23.96%
6か月 パフォーマンス:
+42.58%
1年 パフォーマンス:
-56.01%
1日の値動き範囲:
Value
$7.26
$7.59
1週間の範囲:
Value
$7.26
$8.82
52週間の値動き範囲:
Value
$0.215
$39.84

Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile

Name
名前
Cyclacel Pharmaceuticals Inc
Name
セクター
Healthcare (1151)
Name
電話
908-517-7330
Name
住所
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
Name
職員
12
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
CYCC's Discussions on Twitter

CYCC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CYCC
Cyclacel Pharmaceuticals Inc
7.46 17.22M 74,000 -13.43M -10.54M -9.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-07-18 再開されました Oppenheimer Outperform
2020-04-27 再開されました ROTH Capital Buy
2018-09-07 開始されました Ladenburg Thalmann Buy
2015-10-16 開始されました H.C. Wainwright Buy
2010-02-04 開始されました Roth Capital Buy
2009-10-28 開始されました Merriman Buy
2008-08-12 開始されました Piper Jaffray Buy
2008-03-12 繰り返されました Cantor Fitzgerald Buy
2008-03-12 繰り返されました Collins Stewart Buy
2008-03-12 繰り返されました Needham & Co Buy
2007-11-27 繰り返されました Cantor Fitzgerald Buy
2007-08-10 繰り返されました Cantor Fitzgerald Buy
2007-06-04 繰り返されました Needham & Co Buy
2007-04-23 開始されました Lazard Capital Buy
2007-04-10 開始されました Cantor Fitzgerald Buy
すべてを表示

Cyclacel Pharmaceuticals Inc (CYCC) 最新ニュース

pulisher
01:38 AM

When is the best time to exit Cyclacel Pharmaceuticals Inc.2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser

01:38 AM
pulisher
12:31 PM

Is Cyclacel Pharmaceuticals Inc. stock entering bullish territoryShare Buyback & Real-Time Buy Signal Notifications - Newser

12:31 PM
pulisher
Sep 04, 2025

Can Cyclacel Pharmaceuticals Inc. hit a new high this monthPortfolio Update Summary & High Conviction Buy Zone Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Cyclacel Pharmaceuticals Enters Warrant Exchange Agreement - MSN

Sep 04, 2025
pulisher
Sep 04, 2025

Is Cyclacel Pharmaceuticals Inc. still worth holding after the dipMarket Weekly Review & Weekly Momentum Picks - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Technical analysis overview for Cyclacel Pharmaceuticals Inc. stockBull Run & Daily Risk Controlled Trade Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Using data models to predict Cyclacel Pharmaceuticals Inc. stock movementMarket Sentiment Report & Entry Point Confirmation Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can Cyclacel Pharmaceuticals Inc. ride the EV waveEarnings Overview Summary & Safe Capital Growth Plans - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

Is Cyclacel Pharmaceuticals Inc. stock poised for growthMarket Performance Report & Free Accurate Trade Setup Notifications - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Cyclacel Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - Quantisnow

Sep 04, 2025
pulisher
Sep 04, 2025

What are Cyclacel Pharmaceuticals Inc.’s earnings expectations2025 Pullback Review & Proven Capital Preservation Methods - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

Real time scanner hits for Cyclacel Pharmaceuticals Inc. explained2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Has Cyclacel Pharmaceuticals Inc. formed a bullish divergence2025 Market WrapUp & Weekly Chart Analysis and Guides - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Quantitative breakdown of Cyclacel Pharmaceuticals Inc. recent move2025 Key Lessons & AI Based Buy/Sell Signal Reports - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Top chart patterns to watch in Cyclacel Pharmaceuticals Inc.Weekly Stock Recap & AI Powered Trade Plan Recommendations - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Is a relief rally coming for Cyclacel Pharmaceuticals Inc. holdersPortfolio Profit Report & Precise Swing Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How moving averages guide Cyclacel Pharmaceuticals Inc. tradingJuly 2025 Fed Impact & AI Powered Market Entry Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using R and stats models for Cyclacel Pharmaceuticals Inc. forecastingAnalyst Downgrade & Smart Allocation Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Cyclacel Pharmaceuticals Inc. still a buy after recent gainsJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Why Cyclacel Pharmaceuticals Inc. stock attracts strong analyst attentionM&A Rumor & AI Optimized Trade Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What’s the fair value of Cyclacel Pharmaceuticals Inc. stockJuly 2025 Price Swings & Consistent Income Trade Recommendations - khodrobank.com

Sep 03, 2025
pulisher
Sep 02, 2025

How cyclical is Cyclacel Pharmaceuticals Inc.’s revenue streamJuly 2025 Outlook & Community Verified Watchlist Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Cyclacel Pharmaceuticals Inc. stock risky to hold nowEarnings Growth Summary & Weekly High Conviction Trade Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

What high frequency data says about Cyclacel Pharmaceuticals Inc.Trade Analysis Summary & Weekly Market Pulse Updates - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Market reaction to Cyclacel Pharmaceuticals Inc.’s recent newsWeekly Market Summary & Target Return Focused Stock Picks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

News impact scoring models applied to Cyclacel Pharmaceuticals Inc.Oil Prices & Free Technical Pattern Based Buy Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Cyclacel Pharmaceuticals Amends Stock Purchase Warrants - TipRanks

Sep 02, 2025
pulisher
Sep 02, 2025

Cyclacel Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3) - MarketScreener

Sep 02, 2025
pulisher
Sep 02, 2025

Can Cyclacel Pharmaceuticals Inc. be recession proofWeekly Profit Analysis & Safe Swing Trade Setup Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Cyclacel Pharmaceuticals Inc. stock trending bullishIPO Watch & Weekly Return Optimization Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Is Cyclacel Pharmaceuticals Inc. affected by consumer sentimentQuarterly Earnings Report & Daily Chart Pattern Signals - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Is Cyclacel Pharmaceuticals Inc. gaining market shareJuly 2025 Institutional & Fast Moving Stock Trade Plans - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Signal strength of Cyclacel Pharmaceuticals Inc. stock in tech scannersJuly 2025 Fed Impact & Real-Time Market Trend Scan - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Tools to monitor Cyclacel Pharmaceuticals Inc. recovery probabilityJuly 2025 News Drivers & Verified Swing Trading Watchlist - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What moving averages say about Cyclacel Pharmaceuticals Inc.July 2025 Market Mood & Verified Technical Trade Signals - Newser

Aug 31, 2025

Cyclacel Pharmaceuticals Inc (CYCC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Cyclacel Pharmaceuticals Inc (CYCC) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Lazar David E.
Interim CEO
Feb 26 '25
Sale
0.03
194,628,820
5,507,996
0
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
大文字化:     |  ボリューム (24 時間):